(2S)-2-[8-amino-1-[4-(pyridin-2-ylmethoxy)phenyl]imidazo[1,5-a]pyrazin-3-yl]pyrrolidine-1-carboxylic acid
C23H22N6O3 — CID 146255710
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S)-2-[8-amino-1-[4-(pyridin-2-ylmethoxy)phenyl]imidazo[1,5-a]pyrazin-3-yl]pyrrolidine-1-carboxylic acid
(2S)-2-[8-amino-1-[4-(pyridin-2-ylmethoxy)phenyl]imidazo[1,5-a]pyrazin-3-yl]pyrrolidine-1-carboxylic acid (PubChem CID 146255710) has the molecular formula C23H22N6O3 and a molecular weight of 430.47 g/mol. Its IUPAC name is (2S)-2-[8-amino-1-[4-(pyridin-2-ylmethoxy)phenyl]imidazo[1,5-a]pyrazin-3-yl]pyrrolidine-1-carboxylic acid.
Molecular Properties
| Compound Name | (2S)-2-[8-amino-1-[4-(pyridin-2-ylmethoxy)phenyl]imidazo[1,5-a]pyrazin-3-yl]pyrrolidine-1-carboxylic acid |
|---|---|
| PubChem CID | 146255710 |
| Molecular Formula | C23H22N6O3 |
| Molecular Weight | 430.47 g/mol |
| Exact Mass | 430.18 |
| IUPAC Name | (2S)-2-[8-amino-1-[4-(pyridin-2-ylmethoxy)phenyl]imidazo[1,5-a]pyrazin-3-yl]pyrrolidine-1-carboxylic acid |
| SMILES | Nc1nccn2c([C@@H]3CCCN3C(=O)O)nc(-c3ccc(OCc4ccccn4)cc3)c12 |
| InChI | InChI=1S/C23H22N6O3/c24-21-20-19(15-6-8-17(9-7-15)32-14-16-4-1-2-10-25-16)27-22(29(20)13-11-26-21)18-5-3-12-28(18)23(30)31/h1-2,4,6-11,13,18H,3,5,12,14H2,(H2,24,26)(H,30,31)/t18-/m0/s1 |
| InChIKey | SCAQUNDHXKDDHQ-SFHVURJKSA-N |
| XLogP | 3.77 |
| TPSA | 118.87 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 430.47 |
| LogP ≤ 5 | 3.77 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146255710 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.